Navigation Links
RIPE Pilot Study Suggests Resveratrol May Improve Cognitive Function In The Elderly
Date:11/27/2012

SAN DIEGO, Nov. 27, 2012 /PRNewswire/ -- Findings from the "Resveratrol for Improved Performance in Elders" (RIPE) trial were presented last week at the 65th Annual Scientific Meeting of The Gerontological Society of America, which was hosted at the San Diego Convention Center from November 14 – 18.  The conference offered more than 400 scientific sessions to over 4,000 leaders in the field of aging from around the world.

The RIPE pilot study, a double-blind, placebo-controlled trial conducted by researchers at the University of Florida in Gainesville, followed cognitively intact men and women who orally ingested Resveratrol (provided by Reserveage Organics) in either 300 mg/d or 1000 mg/d doses over a 90-day period. Cognitive assessments were made at baseline and at the end of the study (Day 90) using: Hopkins Verbal Learning Test (HVLT), Digits Forward and Backward (DFB), Controlled Oral Word Association (COWA), Trail Making Tests (TMT: A & B), Digit Symbol Copy number (DSCN), and Digit Symbol Substitution Test (DSST).

Compared to placebo, Resveratrol supplementation taken in the 1000 mg/d dose improved psychomotor (processing) speed and significantly increased hippocampal activation (increased blood flow to the brain). Resveratrol, a natural polyphenolic compound present in various dietary sources including peanuts, grapes, red wine, and Japanese knotweed, has demonstrated a wide range of physiological benefits in humans.

"Our findings are supportive of a short-term course of Resveratrol supplementation for enhancing psychomotor speed and increasing hippocampal activation. We also observed exciting trends suggesting memory was improved," said lead researcher Steve Anton, Ph.D.,** from the Dept. of Aging and Geriatric Research and Institute on Aging at the University of Florida. "The results are very promising and show that Resveratrol may have a predictable positive impact on cognitive function in older adults."

The
'/>"/>

SOURCE Reserveage Organics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Bluechiip Receives First Sales Order from ATCC after Completion of Successful Pilot Trial
2. In Pilot Study, a Peptide Controls Blood Sugar in People with Congenital Hyperinsulinism
3. Ocular Therapeutix Commences Pilot Phase II Travoprost Punctum Plug Study for the Treatment of Glaucoma
4. Systagenix begins pilot with ToolsGroup to optimise inventory levels
5. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
6. Study Showed Patients Treated With The miraDry© System Experienced 82 Percent Sweat Reduction On Average
7. Asubio Initiates Landmark Clinical Study in Spinal Cord Injury
8. New Veridex Alliance Drives Study Of Circulating Tumor Cells In Men With Metastatic Prostate Cancer
9. Shingles Vaccine is Safe, According to New Study
10. Structural Trends to Profoundly Change Life Sciences Industry, Genpact Study Shows
11. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... VIEW, Calif. , July 24, 2014  IRIDEX ... it will release its second quarter 2014 financial results ... 2014. In conjunction with the release, the Company ... at 5:00 p.m. Eastern Time on ... of the quarter and other business developments. ...
(Date:7/24/2014)... 2014 Omnicell, Inc. (NASDAQ: ... supply management solutions and analytics software for healthcare ... to discuss the Company,s Second Quarter 2014 financial ... earnings conference call and webcastWhen: , July ... chairman, president and chief executive officer ...
(Date:7/24/2014)... N.J., July 24, 2014  IGI Laboratories, Inc. (NYSE MKT: ... manufacturing company, announced its financial results for the second quarter ... , Total revenues of $6.5 million in the ... same quarter in 2013 , Total revenues of $13.3 ... increase of 78% over the same period in 2013 ...
Breaking Medicine Technology:Omnicell to Release Second Quarter 2014 Earnings Results on July 31 2IGI Laboratories Announces Second Quarter 2014 Results 2IGI Laboratories Announces Second Quarter 2014 Results 3IGI Laboratories Announces Second Quarter 2014 Results 4IGI Laboratories Announces Second Quarter 2014 Results 5IGI Laboratories Announces Second Quarter 2014 Results 6IGI Laboratories Announces Second Quarter 2014 Results 7
... New results from the largest multicenter clinical trial for ... the International Society for Heart & Lung Transplantation (ISHLT) ...  Results show clinical benefit for the use of Everolimus ... 721 randomized patients at 67 medical centers spanning 5 ...
... April 14, 2011 Oxford Finance Corporation (Oxford), a ... a $2 million equipment loan with Synta Pharmaceuticals Corp. ... compounds for use in Synta,s ongoing clinical trials in ... "Synta Pharmaceuticals has a diverse drug pipeline, including ...
Cached Medicine Technology:Results From Largest Study of Anti-Rejection Therapy for Heart Transplant Patients Will be Released at ISHLT Meeting 2Results From Largest Study of Anti-Rejection Therapy for Heart Transplant Patients Will be Released at ISHLT Meeting 3Results From Largest Study of Anti-Rejection Therapy for Heart Transplant Patients Will be Released at ISHLT Meeting 4Oxford Finance Corporation Provides a $2 Million Equipment Facility to Synta Pharmaceuticals Corp. 2
(Date:7/25/2014)... when genes are switched on or off plays a ... regulate metabolism, UT Southwestern Medical Center researchers have found., ... treat obesity and diabetes, since the transcription factor involved ... to influence the body,s sensitivity to insulin and leptin ... body,s regulation of food intake and sugar disposal, and ...
(Date:7/25/2014)... (PRWEB) July 25, 2014 Innerspire, LLC ... joined the company as a Creative Enrollment Specialist. In ... relationship building skills as well as his accomplished design ... small business clients, and to service the creative ... Additionally, Greg will work with small business owners and ...
(Date:7/25/2014)... The American Brain Tumor Association (ABTA) ... CommYOUnity™” during its annual patient and family conference in ... brain tumor community as we – the first and ... services and funding brain tumor research – extend our ... tumor awareness and getting our materials and services into ...
(Date:7/25/2014)... July 25, 2014 There are 700,000 people ... diagnosed each day. Though when someone hears the words, “you ... are unsure of the next step and where to turn. ... figure out that next step by providing and pursuing the ... than Brian Olson, member of the ABTA’s Board of Directors ...
(Date:7/25/2014)... Progress in understanding the molecular genetics of brain ... brain tumor treatments, according to Patrick Wen, MD, professor ... for Neuro-Oncology, Dana-Farber Cancer Institute. , At the American ... in Chicago, July 25-26, Dr. Wen will moderate a ... the development of new treatments and advancing strategies to ...
Breaking Medicine News(10 mins):Health News:Manipulating key protein in the brain holds potential against obesity and diabetes 2Health News:Innerspire, LLC Continues National Expansion 2Health News:Innerspire, LLC Continues National Expansion 3Health News:Innerspire, LLC Continues National Expansion 4Health News:American Brain Tumor Association Unveils Brand Identity for Newly Launched Volunteer Network 2Health News:American Brain Tumor Association Unveils Brand Identity for Newly Launched Volunteer Network 3Health News:American Brain Tumor Association Board of Directors Member Shares Story of Brain Tumor Survivorship 2Health News:American Brain Tumor Association Board of Directors Member Shares Story of Brain Tumor Survivorship 3Health News:Immunotherapy, Targeted Molecular Therapies Among Promising New Treatments for Brain Tumors 2Health News:Immunotherapy, Targeted Molecular Therapies Among Promising New Treatments for Brain Tumors 3Health News:Immunotherapy, Targeted Molecular Therapies Among Promising New Treatments for Brain Tumors 4
... its truth when then Researchers of Arizona University did a ... D.Martinez and collegues , girls who become overweight or obese ... have a sevenfold increased risk of developing asthma .The boys ... if they are obese , the researchers say. , The ...
... research that suggests high doses of vitamin E may ... prevalent diseases in the world with many ravaging complications, ... heart disease, eye damage, kidney failure, non healing ulcers ... of the nervous system. ,Diabetes is caused by ...
... of Pfizer. The pharmaceutical giant has announced that it ... by the AIDS virus. The decision by the Pfizer comes ... a landmark case against pharmaceutical companies. In an announcement ... be given free of cost to battle HIV through a ...
... Azad Medical College, New Delhi has created history of ... from the American patent office for his technique in ... ,A few weeks ago the American patent office granted ... was able to regenerate organs like the uterus, urethra ...
... West is now sitting up and taking in the aroma ... spices are now the subjects of research by scientists at ... C. Fung and colleagues who conducted the study opine that ... can also double up as an anti bacterial agent. ...
... a little quality time with one's spouse and other partners ... pressure. In a study that used portable monitors to ... pressure was lowest when they were with their partners, regardless ... of the State University of New York, the lead study ...
Cached Medicine News: